Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2025-12-26 @ 10:34 AM
NCT ID:
NCT01952028
Eligibility Criteria:
Inclusion Criteria:
* Genetic confirmation of 2 variants in LAMA2 gene OR muscle biopsy with complete absence of merosin
* Complete authorization to obtain medical records for Congenital Muscle Disease International Registry
* Complete authorization to obtain medical records for National Institutes of Health (NIH)
* Reside in United States or Canada
* Complete registration and intake survey in the Congenital Muscle Disease International Registry
Exclusion Criteria:
\- Individuals with LAMA2-MD who have not had a brain MRI
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01952028
Study Brief:
Protocol Section:
NCT01952028